Skip to main content

Table 1 TILs from Pancreatic Adenocarcinoma are Predominantly CD4+

From: Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors

Patient

CD4+

CD8+

Fragments plated

TIL yield

Yield per 48 fragments

1

31.8

54.3

4

4.97E + 05

5.96E + 06

2

95.4

4.04

9

1.40E + 08

7.47E + 08

3

96.9

1.90

24

1.13E + 07

2.26E + 07

4

96.6

1.34

24

6.40E + 05

1.28E + 06

5

64.0

33.5

23

3.78E + 07

7.89E + 07

6

72.0

21.7

24

2.52E + 07

5.04E + 07

7

60.2

33.0

33

5.32E + 06

7.74E + 06

8

74.5

22.8

12

1.42E + 06

5.68E + 06

9

92.1

5.79

36

3.64E + 07

4.85E + 07

10

41.3

46.5

10

5.90E + 06

2.83E + 07

11

a

a

9

N/A

N/A

12

52.4

34.4

24

ND

ND

13

85.1

12.6

1

2.92E + 06

1.40E + 08

14

49.9

17.9

12

1.80E + 06

7.20E + 06

15

36.9

49.5

5

1.34E + 06

1.29E + 07

16

55.8

38.6

2

6.90E + 05

1.66E + 07

17

60.1

24.2

1

ND

ND

18

67.9

28.7

7

2.37E + 07

1.63E + 08

19

80.7

9.02

14

1.89E + 06

4.68E + 07

20

41.6

47.1

12

7.50E + 06

7.50E + 06

Mean

66.1

25.6

14.3

1.79E + 07

8.31E + 07

SD

21.0

17.0

10.5

  
  1. All TIL analyzed are pre-Rapid Expansion Protocol (REP)
  2. a TIL growth not observed; N/A not applicable, ND no data